🫁 New options for treatment-refractory NTM lung disease?
In a two-center study of 87 patients, bedaquiline was well tolerated; 40% achieved sustained culture negativity and discontinued all therapy.
doi.org/10.1093/annals…
#NTM #pulmonary #ATS @atscommunity
In a two-center study of 87 patients, bedaquiline was well tolerated; 40% achieved sustained culture negativity and discontinued all therapy.
doi.org/10.1093/annals…
#NTM #pulmonary #ATS @atscommunity